Abstract #2410

R2* yield by IDEAL IQ MRI in Evaluating the Expression Status of Glypican-3 in Hepatocellular Carcinoma

Rushi Chen¹, Yan Bai², Ge Zhang², Kaiyu Wang³, and Meiyun Wang²

¹Henan provincial people's hospital& Zhengzhou University People’s Hospital, Zhengzhou, China, ²Henan provincial people's hospital, Zhengzhou, China, ³GE Healthcare, MR Research, Beijing, China

Accurate diagnosis and evaluation of HCC is important for improving the efficiency of HCC treatment and patient prognosis. Glypican-3 (GPC3) has been considered as a promising diagnostic and prognostic biomarker and a target for immune-therapeutic in HCC. Our study aimed to investigate the utility of IDEAL IQ MRI to prospectively evaluate the expression status of GPC3. Our results showed that the intratumoral R2* value was significantly higher in the positive-GPC3 HCC patients than in the negative-GPC3 HCC patients (P=0.003). The IDEAL IQ MRI may have potential for non-invasively predict GPC3 expression status.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.